检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:孙力超[1] 冉宇靓[1] 遇珑[1] 胡海[1] 钟星[1] 孙立新[1] 杨治华[1]
机构地区:[1]中国医学科学院中国协和医科大学肿瘤研究所细胞及分子生物学研究室,北京100021
出 处:《中国肿瘤生物治疗杂志》2008年第4期321-325,共5页Chinese Journal of Cancer Biotherapy
基 金:国家自然科学基金项目(No.30570818);国家重点基础研究发展规划(973)资助项目(No.2002CB513106)~~
摘 要:目的:研制抑制结肠癌细胞与肝窦血管内皮细胞黏附的功能性单抗,鉴定该单抗识别的抗原分子。方法:以人肝窦内皮细胞(human liver sinusoidal endothelial cell,HLSEC)免疫BALB/c小鼠,将小鼠脾细胞与SP2/0细胞融合,采用甲基纤维素选择培养液培养,制备抗HLSEC的单克隆抗体库。采用免疫荧光染色、黏附实验等方法筛选、鉴定能抑制结肠癌Ls174T细胞与肝窦内皮细胞黏附的功能性单克隆抗体。提取肝窦内皮细胞膜蛋白,采用Western blotting方法鉴定单抗识别的功能性抗原蛋白。结果:HLSEC免疫小鼠的脾细胞与SP2/0细胞融合后产生1440个杂交瘤株,获得119株产生抗HLSEC抗体的阳性克隆,其中20株能显著抑制具有肝转移能力的结肠癌Ls174T细胞与HLSEC的黏附;其中15株为IgM型,3株为IgG型,2株测不到重链;其中1株抗黏附能力最强的单抗(黏附抑制率为51%)命名为12B6,该单抗在5~200μg/ml范围内显著阻断HLSEC与Ls174T的黏附,且呈剂量依赖性;单抗12B6所识别的HLSEC抗原蛋白的相对分子质量为46000。结论:建立了抗HLSEC单克隆抗体库,获得了20株具有抑制结肠癌细胞与肝窦血管内皮细胞黏附的功能性抗体,初步鉴定了一种可能参与结肠癌肝转移的黏附分子,为结肠癌的组织器官特异转移机制及靶向治疗的研究奠定了一定的基础。Objective: To screen for functional monoclonal antibody which can inhibit the adhesion between colon cancer cells and human liver sinusoidal endothelial cells (LSECs) , and to identify the specific antigen of the screened antibody. Methods: BALB/c mice were immunized with LSECs, the spleen cells of the immunized mice were fused with SP2/0 cells and cultured on methyl cellulose to establish anti-LSECs monoelonal antibody library. Functional monoclonal antibodies which inhibited the adherence between colon cancer cells (Ls174 T cells) and LSECs were screened and identified by immunofluorescence, ELISA and adhesive assay. The membrane proteins were extracted from LSECs and the specific antigen recognized by monoclonal antibody was detected by Western blotting assay. Results: Totally 1 440 monoclonal antibody clones were obtained by the fusing spleen cells of immunized mice with SP2/0 cells, 199 of the monoclonal antibodies recognized LSECs; and 20 clones, including 15 IgM type, 3 IgG type, and 2 with the heavy strand undetectable, significantly suppressed the adherence between colon cancer cells and LSECs. One of these clones with the strongest anti-adhesive ability ( inhibitory rate 51% ) significantly inhibited the adhesion between colon cancer cells and HLSECs at 15 -200 μg/ml in a dose-dependent manner and reacted with antigens of 46 kD. Conclusion: We have successfully established an anti-HLSEC monoclonal antibody library and obtained 20 functional monoclonal antibodies which can suppress the adherence of colon cancer cells with LSECs. One adhesive molecule which might mediate colon cancer liver metastasis has been preliminarily identified. These antibodies may help to understand the mechanism of organ-specific metastasis of colon cancer cells and shed light on anti-metastasis therapy of colon cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222